Drug Abuse News and Research

RSS

New study explores psychedelic therapy for co-occurring cocaine addiction and depression

A team of UTHealth Houston researchers has been awarded a five-year, $3.4 million grant to study whether psilocybin-assisted therapy is a viable treatment option for individuals with co-occurring cocaine use disorder and major depressive disorder.

22 Oct 2026

Tenant right-to-counsel program may reduce emergency visits among high-risk populations

Residential evictions are associated with adverse health outcomes, particularly among low-income populations.

21 Oct 2026

Study finds both the liver and brain drive distinct symptoms of rare genetic epilepsy

A recent study from Johns Hopkins Medicine reveals that both the liver and brain contribute pathways to differing symptoms of the same rare inherited disorder.

9 Oct 2026

Psilocybin users with depression report higher unmet healthcare needs

In a nationally representative study on psilocybin use and mental health treatment, researchers at the University of California San Diego School of Medicine have found that among people with depression, those who use psilocybin pursue mental health care at similar rates to nonusers.

6 Oct 2026

Many youth with opioid use disorder miss out on treatment

One in 100 adolescents and young adults in the United States has an opioid use disorder (OUD) and, with the rise of fentanyl in the drug supply, overdoses in this age group have risen sharply since 2019.

5 Oct 2026

UC San Diego receives funding to establish the Polysubstance Addiction Research Center

Researchers from University of California San Diego have received a $12.6 million award from the National Institute on Drug Abuse (NIDA) to establish the Polysubstance Addiction Research Center (PARC), a multidisciplinary center designed to uncover the biological factors that contribute to addiction across multiple substances.

30 Sep 2026

Declining benzodiazepine use reflects more cautious medical prescribing practices

The number of benzodiazepine prescriptions like Xanax and Valium dispensed in the United States decreased over the past 10 years, potentially suggesting that doctors have become more cautious when prescribing these sedatives, according to Rutgers Health researchers.

30 Sep 2026

Veterinary sedative in fentanyl supply spikes severe withdrawal cases

A powerful veterinary sedative, medetomidine, is increasingly infiltrating the street supplies of the already deadly opioid fentanyl, with patients suffering from its withdrawal quadrupling in recent years, according to a new analysis by researchers at the Perelman School of Medicine at the University of Pennsylvania.

29 Sep 2026

Study finds rising cannabis use disorder among older adults

Cannabis use is becoming increasingly common among older adults in the United States, but less is known about how often cannabis use may become problematic in this population.

28 Sep 2026

Persistent stigma creates barriers to modern HIV prevention methods

For decades, HIV (human immunodeficiency virus) has been surrounded by fear, misinformation and stigma.

18 Sep 2026

Psilocybin study explores new treatment for cocaine use disorder

Albert Arias, MD, chief of addiction psychiatry at Carilion Clinic, has received an award from the National Institute on Drug Abuse (NIDA) to research how psilocybin, a psychedelic compound being studied for several psychiatric and substance use disorders, can offer a new approach for people with cocaine use disorder.

4 Sep 2026

Social media messages could empower parents to prevent teen vaping

Parents are an important line of defense against teen vaping, yet many lack the knowledge and tools needed to recognize vaping products, understand their risks and prevent their children from using them.

31 Aug 2026

Loneliness can reprogram the brain to increase alcohol use

Loneliness can reprogram the brain in ways that push alcohol consumption, reports a new preclinical study led by Northwestern University and the Salk Institute for Biological Studies.

25 Aug 2026

Real-world study shows Oregon psilocybin services relieve mental health symptoms

People participating in an Oregon Health & Science University-led study of state-regulated psilocybin services reported relief from symptoms of anxiety, depression and post-traumatic stress disorder - with almost two-thirds declaring the experience to be among the most meaningful of their life.

19 Aug 2026

New CapuchinAI system automates cognitive testing of wild primates

Scientists created an AI system that uses facial recognition and real-time, touchscreen testing to automate cognitive studies of capuchin monkeys in the wild.

29 Jul 2026

Individualized treatment speeds recovery for babies with opioid withdrawal

A major new study shows that individualized treatment for babies born with opioid withdrawal can speed recovery and reduce time spent in the hospital.

24 Jul 2026

Federal nicotine reduction strategy could boost productivity and save lives

Implementing a federal nicotine reduction strategy may prevent millions of premature deaths, boost productivity, and significantly close smoking disparity gaps for individuals with major depression, according to Rutgers Health researchers.

16 Jul 2026

Long-term study proves brain stimulation safely restores touch

What if people who have lost the ability to feel their hands could get that sense back - not through a prosthetic glove, but through tiny pulses of electricity delivered directly to the brain?

16 Jul 2026

Low-nicotine cigarettes do not cause increased compensatory smoking

People who switch to cigarettes with dramatically reduced nicotine levels are unlikely to smoke more cigarettes or inhale more smoke to compensate for the lower nicotine content, according to a new study led by researchers at Wake Forest University School of Medicine and published in JAMA Network Open.

15 Jul 2026

New study explores health effects of hookah smoking methods

Hookah is often seen as a cleaner alternative to smoking cigarettes, but researchers at The University of Texas at Arlington are launching a new study to put that assumption to the test.

7 Jul 2026